Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy

Clinical trial NCT06985485 · RECRUITING

Trial details

NCT number: NCT06985485
Sponsor: The First Affiliated Hospital of Soochow University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Immunotherapy Blinatumomab Inotuzumab Ozogamicin

Start date: 2025-05-17
Primary completion: 2027-12-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.